Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer

30.05.2008 08:00:06
Roche Pharmaceuticals: Basel, Switzerland (ots/PRNewswire) - New data from a Phase II trial presented at the American Society of Clinical Oncology (ASCO) 2008 meeting showed that half of the patients with advanced, HER2-positive metastatic breast cancer whose disease had progressed during a Herceptin-containing regimen benefited from a combination of Herceptin and pertuzumab.(1) Pertuzumab inhibits the pairing of HER2 with other HER receptors, a key mechanism of ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




Erste Taxan-basierte Anthrazyklin-freie Chemotherapie in Kombination ...

Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer Herceptin(R) Helps Eradicate HER2-Positive Breast


Frauen gegen Gebärmutterhalskrebs (Women Against Cervical Cancer - WACC ...

Herceptin(R) Helps Eradicate HER2-Positive Breast Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer


Bankkaufmann - News

Auf dieser Seite finden Sie Neuigkeiten zum Thema: Aktuelle Wirtschaftsnews, Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive


Presseportal: Pressemappen-Katalog

New Report Shows That Despite Poor Survival Rates Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer


NEW ROCHE DATA TO BE PRESENTED AT ASCO OFFERS FURTHER HOPE FOR CANCER ...

No.1025, Poster No.6.E450b pertuzumab Results of a phase II trial of Tuesday Herceptin delivers high cure rates for women with HER2 positive early breast